摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-Cyclohexanedicarboxylic acid, monoethyl ester | 1195565-22-0

中文名称
——
中文别名
——
英文名称
1,3-Cyclohexanedicarboxylic acid, monoethyl ester
英文别名
3-(Ethoxycarbonyl)cyclohexanecarboxylic acid;3-ethoxycarbonylcyclohexane-1-carboxylic acid
1,3-Cyclohexanedicarboxylic acid, monoethyl ester化学式
CAS
1195565-22-0
化学式
C10H16O4
mdl
——
分子量
200.235
InChiKey
WFXPHQCHMAPWEB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • INHIBITORS OF INFLUENZA VIRUSES REPLICATION
    申请人:Charifson Paul S.
    公开号:US20120171245A1
    公开(公告)日:2012-07-05
    Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    抑制生物样本或患者中流感病毒的复制、减少生物样本或患者中流感病毒量以及治疗患者流感的方法,包括向所述生物样本或患者施用有效量的由结构公式(I)表示的化合物: 或其药用可接受盐,其中结构公式(IA)的值如本文所述。由结构公式(IA)或其药用可接受盐表示的化合物,其中结构公式(IA)的值如本文所述。药物组合物包括有效量的上述化合物或其药用可接受盐,以及药用可接受载体、佐剂或车辆。
  • [EN] INHIBITORS OF INFLUENZA VIRUSES REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DES VIRUS DE LA GRIPPE
    申请人:VERTEX PHARMA
    公开号:WO2012083117A1
    公开(公告)日:2012-06-21
    Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    抑制流感病毒在生物样本或患者中复制的方法,减少生物样本或患者中流感病毒的数量,以及治疗患者的流感,包括向所述生物样本或患者投与结构式(I)所代表的化合物的有效量或其药学上可接受的盐,其中结构式(I)的值如本文所述。一种化合物由结构式(I)或其药学上可接受的盐所代表,其中结构式(I)的值如本文所述。一种药物组合物包括这种化合物或其药学上可接受的盐的有效量,以及药学上可接受的载体、辅料或溶剂。
  • Process for producing organic compound epoxy resin composition, cured article obtained from the epoxy resin, and semiconductor device obtained with epoxy resin
    申请人:——
    公开号:US20040260039A1
    公开(公告)日:2004-12-23
    There are disclosed a process for producing an organic compound in the presence of a particular substituted triarylphosphine compound, particularly, a process for producing an oxyalkylene derivative at a high yield using the above compound which is very active and easy to handle, by reacting an organic epoxy compound with a carboxylic acid ester, a carboxylic acid anhydride, a sulfonic acid ester or a carbonic acid ester, and an epoxy resin composition using a particular substituted triarylphosphine compound as a curing accelerator, a cured material of the composition and a semiconductor device using the composition.
    本文披露了一种在特定取代三芳基膦化合物存在下生产有机化合物的工艺,特别是一种使用上述化合物作为催化剂,通过将有机环化合物与羧酸羧酸酐磺酸碳酸反应,以及使用特定取代三芳基膦化合物作为固化促进剂的环树脂组合物的工艺,从而高产地生产代烷基衍生物,还包括该组合物的固化材料和使用该组合物的半导体器件。
  • PROCESS FOR PRODUCING EXPANDABLE STYRENE POLYMER COMPOSITIONS
    申请人:Husemann Wolfram
    公开号:US20110291040A1
    公开(公告)日:2011-12-01
    A composition comprising at least one expandable styrene polymer component and at least one cyclohexanecarboxylic ester and also optionally further components can be processed to mechanically robust foam materials.
    本发明涉及一种组合物,包括至少一种可膨胀苯乙烯聚合物组分和至少一种环己烷羧酸,还可以选择性地加入其他组分,可加工成具有机械强度的泡沫材料。
  • CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS
    申请人:Mack Helmut
    公开号:US20110232825A1
    公开(公告)日:2011-09-29
    The invention provides an adhesive or sealant comprising at least (A) one compound selected from the group consisting of silylated polyurethanes, silylated polyureas, silylated polyethers, silylated polysulfides and silyl-terminated acrylates, and at least (B) one cyclohexane polycarboxylic acid derivative. The composition has enhanced extensibility with good adhesion properties and high tensile strength. A process is disclosed for preparing the adhesive or sealant, and also disclosed is the use thereof for producing material bonds between parts to be joined.
    本发明提供了一种粘合剂或密封剂,包括至少(A)从包括化聚化聚氨基甲酸化聚醚、化聚硫化物基终止丙烯酸的群组中选择的一种化合物,以及至少(B)一种环己烷羧酸生物。该组合物具有良好的粘附性和高拉伸强度的增强延展性。还公开了制备粘合剂或密封剂的过程,并公开了将其用于在要连接的零件之间产生材料粘结的用途。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸